{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:13:48Z","timestamp":1790644428492,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There are limited data regarding the factors associated with hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. We sought to determine the prevalence and factors associated with HCC in NAFLD patients with or without cirrhosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adults with NAFLD (June 2015 to May 2020) were identified using the electronic health record database (Explorys Inc, Cleveland, OH) from 26 major integrated US healthcare systems. The prevalence of HCC was calculated. Multivariable analyses adjusting for covariates were performed to evaluate the associated risk factors and the presence of HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 392,800 NAFLD patients were identified. Among 1110 patients with HCC, 170 (15.3%) had no cirrhosis. The prevalence of HCC in non-cirrhotic and cirrhotic NAFLD patients was 4.6\/10,000 persons (95% CI 3.9\u20135.3), and 374.4\/10,000 persons (95% CI 350.9\u2013398.8), respectively. Age\u2009&gt;\u200965\u00a0years (adjusted OR; 3.37, 95% CI 2.47\u20134.59), ever had elevated alanine aminotransferase (2.69; 2.14\u20133.37), male gender (2.57; 1.88\u20133.49), smoker (1.75; 1.23\u20132.49), and diabetes (1.56; 1.15\u20132.11) were associated with HCC in non-cirrhotic NAFLD (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The prevalence of HCC in the non-cirrhotic with all five risk factors was 45.5\/10,000 persons (95% CI 17.4\u201373.6). The factors associated with HCC in cirrhotic NAFLD included clinical decompensation, age\u2009&gt;\u200965\u00a0years, male gender, Hispanic race, elevated alanine aminotransferase, diabetes and smoker (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These data identified the major risk factors for the development of HCC in NAFLD patients. In the non-cirrhotics, older male patients with smoking history, diabetes and an elevated alanine aminotransferase had highest risk and may need increased judicious monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-021-01978-0","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T05:02:42Z","timestamp":1634792562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study"],"prefix":"10.1186","volume":"21","author":[{"given":"Kanokwan","family":"Pinyopornpanish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Khoudari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohannad Abou","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaisiri","family":"Angkurawaranon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokporn","family":"Pinyopornpanish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Dasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"issue":"5","key":"1978_CR1","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/hep.29546","volume":"67","author":"AM Allen","year":"2018","unstructured":"Allen AM, Therneau TM, Larson JJ, Coward A, Somers VK, Kamath PS. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study. Hepatology. 2018;67(5):1726\u201336.","journal-title":"Hepatology"},{"issue":"4","key":"1978_CR2","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","volume":"17","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Stepanova M, Ong JP, Jacobson IM, Bugianesi E, Duseja A, Eguchi Y, Wong VW, Negro F, Yilmaz Y, et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol. 2019;17(4):748-755.e743.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"1978_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16(7):411\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"1978_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/apt.14937","volume":"48","author":"JG Stine","year":"2018","unstructured":"Stine JG, Wentworth BJ, Zimmet A, Rinella ME, Loomba R, Caldwell SH, Argo CK. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases. Aliment Pharmacol Ther. 2018;48(7):696\u2013703.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1978_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hep.28368","volume":"63","author":"F Piscaglia","year":"2016","unstructured":"Piscaglia F, Svegliati-Baroni G, Barchetti A, Pecorelli A, Marinelli S, Tiribelli C, Bellentani S. Group H-NIS: clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study. Hepatology. 2016;63(3):827\u201338.","journal-title":"Hepatology"},{"issue":"10","key":"1978_CR6","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1002\/ijc.25797","volume":"128","author":"J Ertle","year":"2011","unstructured":"Ertle J, Dechene A, Sowa JP, Penndorf V, Herzer K, Kaiser G, Schlaak JF, Gerken G, Syn WK, Canbay A. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer. 2011;128(10):2436\u201343.","journal-title":"Int J Cancer"},{"issue":"5","key":"1978_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cgh.2011.01.023","volume":"9","author":"K Yasui","year":"2011","unstructured":"Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, Shima T, Kanbara Y, Saibara T, Mori T, et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011;9(5):428\u201333 (quiz e450).","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1978_CR8","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s12072-015-9679-0","volume":"10","author":"B Mohamad","year":"2016","unstructured":"Mohamad B, Shah V, Onyshchenko M, Elshamy M, Aucejo F, Lopez R, Hanouneh IA, Alhaddad R, Alkhouri N. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. Hepatol Int. 2016;10(4):632\u20139.","journal-title":"Hepatol Int"},{"issue":"1","key":"1978_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","volume":"14","author":"S Mittal","year":"2016","unstructured":"Mittal S, El-Serag HB, Sada YH, Kanwal F, Duan Z, Temple S, May SB, Kramer JR, Richardson PA, Davila JA. Hepatocellular carcinoma in the absence of cirrhosis in united states veterans is associated with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2016;14(1):124-131.e121.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1978_CR10","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","volume":"155","author":"F Kanwal","year":"2018","unstructured":"Kanwal F, Kramer JR, Mapakshi S, Natarajan Y, Chayanupatkul M, Richardson PA, Li L, Desiderio R, Thrift AP, Asch SM, et al. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology. 2018;155(6):1828-1837.e1822.","journal-title":"Gastroenterology"},{"issue":"6","key":"1978_CR11","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/liv.14087","volume":"39","author":"B Bengtsson","year":"2019","unstructured":"Bengtsson B, Stal P, Wahlin S, Bjorkstrom NK, Hagstrom H. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis. Liver Int. 2019;39(6):1098\u2013108.","journal-title":"Liver Int"},{"issue":"9","key":"1978_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/apt.14261","volume":"46","author":"R Pais","year":"2017","unstructured":"Pais R, Fartoux L, Goumard C, Scatton O, Wendum D, Rosmorduc O, Ratziu V. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period. Aliment Pharmacol Ther. 2017;46(9):856\u201363.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1978_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ajg.2011.327","volume":"107","author":"Y Kawamura","year":"2012","unstructured":"Kawamura Y, Arase Y, Ikeda K, Seko Y, Imai N, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am J Gastroenterol. 2012;107(2):253\u201361.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1978_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"9","key":"1978_CR15","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1111\/jgh.14608","volume":"34","author":"K Kodama","year":"2019","unstructured":"Kodama K, Kawaguchi T, Hyogo H, Nakajima T, Ono M, Seike M, Takahashi H, Nozaki Y, Kawanaka M, Tanaka S, et al. Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis. J Gastroenterol Hepatol. 2019;34(9):1626\u201332.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"1978_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/amiajnl-2011-000782","volume":"19","author":"DC Kaelber","year":"2012","unstructured":"Kaelber DC, Foster W, Gilder J, Love TE, Jain AK. Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data. J Am Med Inform Assoc. 2012;19(6):965\u201372.","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"1978_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/cam4.1998","volume":"8","author":"K Tarao","year":"2019","unstructured":"Tarao K, Nozaki A, Ikeda T, Sato A, Komatsu H, Komatsu T, Taguri M, Tanaka K. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment. Cancer Med. 2019;8(3):1054\u201365.","journal-title":"Cancer Med"},{"issue":"7","key":"1978_CR18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/ijc.30784","volume":"141","author":"TY Lee","year":"2017","unstructured":"Lee TY, Wu JC, Yu SH, Lin JT, Wu MS, Wu CY. The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease. Int J Cancer. 2017;141(7):1307\u201314.","journal-title":"Int J Cancer"},{"issue":"42","key":"1978_CR19","doi-asserted-by":"publisher","first-page":"72959","DOI":"10.18632\/oncotarget.20127","volume":"8","author":"KF Yao","year":"2017","unstructured":"Yao KF, Ma M, Ding GY, Li ZM, Chen HL, Han B, Chen Q, Jiang XQ, Wang LS. Meta-analysis reveals gender difference in the association of liver cancer incidence and excess BMI. Oncotarget. 2017;8(42):72959\u201371.","journal-title":"Oncotarget"},{"issue":"48","key":"1978_CR20","doi-asserted-by":"publisher","first-page":"40140","DOI":"10.1074\/jbc.M112.348763","volume":"287","author":"W Yang","year":"2012","unstructured":"Yang W, Lu Y, Xu Y, Xu L, Zheng W, Wu Y, Li L, Shen P. Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs). J Biol Chem. 2012;287(48):40140\u20139.","journal-title":"J Biol Chem"},{"key":"1978_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fgene.2016.00168","volume":"7","author":"OK Cheung","year":"2016","unstructured":"Cheung OK, Cheng AS. Gender differences in adipocyte metabolism and liver cancer progression. Front Genet. 2016;7:168.","journal-title":"Front Genet"},{"issue":"1","key":"1978_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12916-019-1321-x","volume":"17","author":"M Alexander","year":"2019","unstructured":"Alexander M, Loomis AK, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, Pasqua A, Lapi F, Rijnbeek P, Mosseveld M, et al. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts. BMC Med. 2019;17(1):95.","journal-title":"BMC Med"},{"issue":"7","key":"1978_CR23","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/ijc.26165","volume":"130","author":"C Wang","year":"2012","unstructured":"Wang C, Wang X, Gong G, Ben Q, Qiu W, Chen Y, Li G, Wang L. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer. 2012;130(7):1639\u201348.","journal-title":"Int J Cancer"},{"issue":"7","key":"1978_CR24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41416-018-0007-z","volume":"118","author":"JL Petrick","year":"2018","unstructured":"Petrick JL, Campbell PT, Koshiol J, Thistle JE, Andreotti G, Beane-Freeman LE, Buring JE, Chan AT, Chong DQ, Doody MM, et al. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the Liver Cancer Pooling Project. Br J Cancer. 2018;118(7):1005\u201312.","journal-title":"Br J Cancer"},{"issue":"4","key":"1978_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/jebm.12270","volume":"10","author":"O Abdel-Rahman","year":"2017","unstructured":"Abdel-Rahman O, Helbling D, Schob O, Eltobgy M, Mohamed H, Schmidt J, Giryes A, Mehrabi A, Iype S, John H, et al. Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: an updated systematic review of 81 epidemiological studies. J Evid Based Med. 2017;10(4):245\u201354.","journal-title":"J Evid Based Med"},{"issue":"9","key":"1978_CR26","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/liv.12226","volume":"33","author":"S Verma","year":"2013","unstructured":"Verma S, Jensen D, Hart J, Mohanty SR. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int. 2013;33(9):1398\u2013405.","journal-title":"Liver Int"},{"issue":"11","key":"1978_CR27","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/hepr.12656","volume":"46","author":"S Ballestri","year":"2016","unstructured":"Ballestri S, Nascimbeni F, Romagnoli D, Lonardo A. The independent predictors of non-alcoholic steatohepatitis and its individual histological features: insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Hepatol Res. 2016;46(11):1074\u201387.","journal-title":"Hepatol Res"},{"issue":"2","key":"1978_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","volume":"16","author":"NE Rich","year":"2018","unstructured":"Rich NE, Oji S, Mufti AR, Browning JD, Parikh ND, Odewole M, Mayo H, Singal AG. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(2):198-210.e192.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1978_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/hep.24397","volume":"54","author":"TM Welzel","year":"2011","unstructured":"Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology. 2011;54(2):463\u201371.","journal-title":"Hepatology"},{"issue":"4","key":"1978_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cgh.2008.02.012","volume":"6","author":"T Ohki","year":"2008","unstructured":"Ohki T, Tateishi R, Sato T, Masuzaki R, Imamura J, Goto T, Yamashiki N, Yoshida H, Kanai F, Kato N, et al. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Clin Gastroenterol Hepatol. 2008;6(4):459\u201364.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1978_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2008.03.073","volume":"135","author":"CL Chen","year":"2008","unstructured":"Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, Wang LY, Sun CA, Lu SN, Chen DS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B\/C infection: a follow-up study in Taiwan. Gastroenterology. 2008;135(1):111\u201321.","journal-title":"Gastroenterology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-021-01978-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T05:12:55Z","timestamp":1634793175000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-021-01978-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1978"],"URL":"https:\/\/doi.org\/10.1186\/s12876-021-01978-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"assertion":[{"value":"1 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics and consent were not required as it was a secondary analysis of an anonymizes dataset<b>.<\/b> All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"394"}}